Showing results (4021-4030 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|April 9, 2005
Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutationThorsten H Ecke, Horst H Schlechte, Guntram Schulze, et al.Anticancer Research|April 9, 2005
High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility studyA Gonçalves, A C Braud, F Viret, et al.Anticancer Research|July 23, 2005
Clinical relevance of tumor markers for the control of chemotherapyJ Finek, L Holubec, O Topolcan, et al.Anticancer Research|August 9, 2005
Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronideGalal A Alshafie, Joel R Walker, Robert W Curley, et al.Anticancer Research|July 22, 2005
Brain metastases in breast cancer--an in vitro study to evaluate new systemic chemotherapeutic optionsA Honig, L Rieger, A Sutterlin, et al.Anticancer Research|July 22, 2005
Induction of apoptosis in human breast cancer and trophoblast tumor cells by galectin-1Irmi Wiest, Christian Seliger, Hermann Walzel, et al.Anticancer Research|July 22, 2005
Further evidence for prolongation of survival of pancreatic cancer patients by efficacy orientated sequential polychemotherapy (EOSPC) based on serial tumor marker determinations (CA 19-9/CEA)R Klapdor, M Bahlo, A BabinskyAnticancer Research|July 22, 2005
Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 geneReinhard E Friedrich, Lan Kluwe, C Fünsterer, et al.Anticancer Research|July 22, 2005
Serum selenium in head and neck cancer patients--a new marker of tumor activity?Jens Büntzel, Oliver Micke, Michael Glatzel, et al.Pageof 2,589